Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell-T cell activation in multiple sclerosis

J W Lindsey1, R H Kerman, J S Wolinsky

  • 1Department of Neurology, University of Texas-Houston Medical School 77030, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Treatment of Burns.

The Southern medical record·2022
Same author

A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2017
Same author

Antivirus immune activity in multiple sclerosis correlates with MRI activity.

Acta neurologica Scandinavica·2015
Same author

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics.

Multiple sclerosis and related disorders·2015
Same author

The antibody response to Epstein-Barr virions is altered in multiple sclerosis.

Journal of neuroimmunology·2012
Same author

Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial.

Neurology·2012
Same journal

Association of epiretinal membranes with disability in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

This study investigated T cell activation in multiple sclerosis (MS). Researchers found no significant differences in T cell proliferation between MS patients and controls, suggesting this pathway is not a major factor in MS.

Area of Science:

  • Immunology
  • Neuroimmunology
  • Cellular Biology

Background:

  • Activated T cells can stimulate resting T cells non-specifically, potentially amplifying immune responses.
  • This T cell-T cell activation pathway may be implicated in multiple sclerosis (MS) exacerbations post-viral infection and potentially in MS etiology.
  • The in vivo significance of T cell-T cell activation remains unclear.

Purpose of the Study:

  • To test the hypothesis that excessive T cell-T cell activation occurs in multiple sclerosis (MS) patients.
  • To compare T cell proliferation in MS patients versus controls using in vitro assays.

Main Methods:

  • In vitro proliferation assays were utilized.
  • T cells from MS patients and healthy controls were compared.

Related Experiment Videos

  • Cells were tested both as responder cells and stimulator cells.

    • Main Results:

    • T cells from MS patients showed slightly less proliferation when acting as responder cells compared to controls.
    • Activated T cells from MS patients stimulated slightly more non-specific proliferation when acting as stimulator cells than controls.
    • Neither observed difference in proliferation was statistically significant.

    Conclusions:

    • T cell proliferation in response to activated T cells is comparable between MS patients and control subjects.
    • The findings suggest that T cell-T cell activation is unlikely to be a primary factor in the etiology or exacerbation of MS.
    • Further research may explore other immune mechanisms in MS pathogenesis.